From GlobeNewswire: 2024-04-12 14:00:00

The global chemotherapy market is projected to grow from USD 8.6 billion in 2023 to USD 16.2 billion by 2033, with a CAGR of 6.54%. Chemotherapy uses medicine to kill cancer cells and inhibit their growth, offering targeted and immune therapy options. Alkylating agents dominate the market, with leukemia showing significant growth. North America leads, but Europe is expected to grow fast due to rising cancer cases. Key players include Pfizer, Sanofi, and Johnson & Johnson. In May 2022, Gland Pharma launched the generic cancer treatment drug Bortezomib for Injection in the US market.

The chemotherapy market is segmented by drug class, indication, route of drug administration, and end-user. Mitotic inhibitors, alkylating agents, and antimetabolites are common drug classes. Breast cancer and leukemia are growing indications, while the oral route of administration is preferred. Hospitals & clinics are key end-users. North America dominates the market, followed by Europe, driven by rising R&D spending for chemotherapy. Competitive analysis reveals key players like Pfizer, Sanofi, and Johnson & Johnson. Major vendors in the global chemotherapy market are Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc, GlaxoSmithKline Plc., Novartis AG, Eli Lilly & Company, Merck & Co., Teva Pharmaceuticals, Celgene Corporation, Bayer AG, Bristol-Myers Squibb, Boehringer Ingelheim, Takeda Pharmaceutical Company Limited, Schering-Plough, Chemo Espana SL, and Others.

The growing prevalence of cancer, rising healthcare costs, and support from government organizations are driving the global chemotherapy market. However, high development costs, expensive clinical trials, side effects, and drug resistance are challenges. Europe is expected to grow rapidly, with Germany leading and the UK showing strong growth. Research suggests that the market will continue to expand due to increasing cancer cases worldwide. The oncology market is dynamic, with major players continually innovating and investing in R&D. Advancements in chemotherapy drugs and treatment methods offer hope for cancer patients.



Read more at GlobeNewswire: Global Chemotherapy Market Size To Exceed USD 16.2 Billion